Sponsor content
49 result(s) found, displaying 1 to 10
-
Australian Public Assessment Report (AusPAR)Eladynos (abaloparatide) has been approved for the treatment of osteoporosis in postmenopausal women at increased risk of fracture.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ELADYNOS abaloparatide 2 mg/mL solution for injection cartridge in a prefilled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for YSELTY linzagolix (as choline) 100 mg film coated tablet blister pack.
-
Prescription medicine registrationActive ingredients: abaloparatide.
-
Prescription medicine registrationActive ingredients: linzagolix choline.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRAROSA prasterone 6.5 mg pessary blister pack.
-
Australian Public Assessment Report (AusPAR)Intrarosa (prasterone) has been approved for the treatment of vulvar and vaginal atrophy.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for GANIRELIX THERAMEX ganirelix (as acetate) 250 microgram/0.5 mL solution for injection prefilled syringe.
-
Prescription medicine decision summaryTGA decision: Intrarosa (prasterone) is approved to treat vulvar and vaginal atrophy in postmenopausal women.
-
Pages
- Current page 1
- Page 2
- Page 3
- Page 4
- Page 5
- Next page Next ›
- Last page Last »